Growth Metrics

DBV Technologies (DBVT) Net Cash Flow (2014 - 2026)

DBV Technologies (DBVT) reported Net Cash Flow of $39.5 million for Q1 2026, up 296.52% year-over-year from $10.0 million in Q1 2025, and down 67.93% on a QoQ basis from $123.2 million in Q4 2025.

DBV Technologies (DBVT) has 13 years of Net Cash Flow data on file, last reported at $39.5 million in Q1 2026.

  • Quarterly Net Cash Flow rose 296.52% year-over-year to $39.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $213.2 million (up 342.7% YoY) and the FY2025 annual result came in at $153.6 million, up 246.81% from the prior year.
  • Net Cash Flow retreated to $39.5 million in Q1 2026 per DBVT's latest filing, from $123.2 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $184.9 million in Q2 2022 and bottomed at -$36.9 million in Q1 2024.
  • The 5-year median for Net Cash Flow is -$20.1 million (2025), against an average of $9.0 million.
  • The widest annual swing landed in 2023, when Net Cash Flow plunged 1200.0%; it then surged 1242.17% in 2025.
  • Tracing DBVT's Net Cash Flow over 5 years: stood at -$24.2 million in 2022, then surged by 41.9% to -$14.1 million in 2023, then increased by 23.31% to -$10.8 million in 2024, then surged by 1242.17% to $123.2 million in 2025, then tumbled by 67.93% to $39.5 million in 2026.
  • Per Business Quant, the three latest DBVT Net Cash Flow figures stand at $39.5 million (Q1 2026), $123.2 million (Q4 2025), and -$32.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 2.44 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 625.70 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -2.44 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 457.40 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -152.20 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 60.68 Mn
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn 39.50 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 39.50 Mn
Mar 31, 2026 39.50 Mn
Dec 31, 2025 123.17 Mn
Dec 31, 2025 123.17 Mn
Sep 30, 2025 -32.55 Mn
Sep 30, 2025 -32.55 Mn
Jun 30, 2025 83.11 Mn
Jun 30, 2025 83.11 Mn
Mar 31, 2025 -20.10 Mn
Mar 31, 2025 -20.10 Mn
Dec 31, 2024 -10.78 Mn
Dec 31, 2024 -10.78 Mn
Sep 30, 2024 -22.56 Mn
Sep 30, 2024 -22.56 Mn
Jun 30, 2024 -34.42 Mn
Jun 30, 2024 -34.42 Mn
Mar 31, 2024 -36.89 Mn
Mar 31, 2024 -36.89 Mn
Dec 31, 2023 -14.06 Mn
Dec 31, 2023 -14.06 Mn
Sep 30, 2023 -20.73 Mn
Sep 30, 2023 -20.73 Mn
Jun 30, 2023 -18.09 Mn
Jun 30, 2023 -18.09 Mn
Mar 31, 2023 -20.81 Mn
Mar 31, 2023 -20.81 Mn
Dec 31, 2022 -24.20 Mn
Dec 31, 2022 -24.20 Mn
Sep 30, 2022 -20.71 Mn
Sep 30, 2022 -20.71 Mn
Jun 30, 2022 184.87 Mn
Jun 30, 2022 184.87 Mn
Mar 31, 2022 -1.60 Mn
Mar 31, 2022 -1.60 Mn
Dec 31, 2021 -18.89 Mn
Dec 31, 2021 -18.89 Mn
Sep 30, 2021 -24.07 Mn
Sep 30, 2021 -24.07 Mn
Jun 30, 2021 -29.50 Mn
Jun 30, 2021 -29.50 Mn
Mar 31, 2021 -35.95 Mn
Mar 31, 2021 -35.95 Mn
Dec 31, 2020 -34.24 Mn
Dec 31, 2020 -34.24 Mn
Sep 30, 2020 -44.06 Mn
Sep 30, 2020 -44.06 Mn
Mar 31, 2020 100.00 Mn
Mar 31, 2020 100.00 Mn
Dec 31, 2019 125.70 Mn
Dec 31, 2019 125.70 Mn
Sep 30, 2019 -51.00 Mn
Sep 30, 2019 -51.00 Mn
Jun 30, 2019 -86.71 Mn
Jun 30, 2019 -86.71 Mn
Dec 31, 2018 -317.38 Mn
Dec 31, 2018 -317.38 Mn
Sep 30, 2018 29.92 Mn
Sep 30, 2018 29.92 Mn
Jun 30, 2018 -77.78 Mn
Jun 30, 2018 -77.78 Mn
Dec 31, 2017 -143.82 Mn
Dec 31, 2017 -143.82 Mn
Dec 31, 2016 -73.25 Mn
Dec 31, 2016 -73.25 Mn
Dec 31, 2015 -10.15 Mn
Dec 31, 2015 -10.15 Mn
Dec 31, 2014 -12.15 Mn
Dec 31, 2014 -12.15 Mn